Grade 3 Meningioma
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Lutathera for the Treatment of Inoperable, Progressive Meningioma After External Beam Radiation Therapy (NCT04082520) | Mayo Clinic | 2020-04-14 |
| Nivolumab and Multi-fraction Stereotactic Radiosurgery With or Without Ipilimumab in Treating Patients With Recurrent Grade II-III Meningioma (NCT03604978) | National Cancer Institute (NCI) | 2019-06-17 |
Track Grade 3 Meningioma automatically
Every clearance here is in the API, with alerts when new ones post.